Article

Determination of essential biomarkers in lung cancer: a real-world data study in Spain.

2022-02-11

Abstract excerpt

<h4>Background: </h4> The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself. This work aims to study the situation of biomarker testing in Spain. Patients and Methods: The Thoracic Tumours Registry (TTR) is an observational, prospective, reg...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c7324baa-f0d8-5fb6-a36f-6bee0bdee7ba
DOI: 10.21203/rs.3.rs-1275497/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Determination of essential biomarkers in lung cancer: a real-world data study in Spain.DOI 10.21203/rs.3.rs-1275497/v1Read

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).Semantic proximity Read

[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].Semantic proximity Read

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Semantic proximity Read

Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice.Semantic proximity Read

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry.Semantic proximity Read

Profiling diagnostic Approach of Thoracic Malignancies in Indonesia’s National Cancer CentreSemantic proximity Read

The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.Semantic proximity Read

Prognostic and predictive biomarkers in non-small cell lung carcinoma.Semantic proximity Read

Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil.Semantic proximity Read

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).Semantic proximity Read

Tissue and Blood Biomarkers in Lung Cancer: A Review.Semantic proximity Read

Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.Semantic proximity Read